This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Libramen Naturals Inc.. Active years: 2018-2019.
Company Filing History:
Years Active: 2018-2019
Title: Patricia Giuliani: Innovator in G-Protein Coupled Receptor Research
Introduction
Patricia Giuliani is a prominent inventor based in Chieti, Italy. She has made significant contributions to the field of biochemistry, particularly in the area of G-protein coupled receptors. With a total of 2 patents to her name, her work is paving the way for advancements in cellular biology and pharmacology.
Latest Patents
Giuliani's latest patents focus on transformed cell lines expressing non-endogenous cell-surface selective guanosine-responsive G-protein coupled receptors. The first patent discloses cell lines transformed to express G-Protein Coupled Receptor GPCR22, which are useful for identifying guanosine analogues and other ligands to the receptor. Techniques for transforming Drosophila Schneider 2 cells and human astrocytoma 1321N1 cells to express GPCR22 are also detailed. The transformed cell lines may be instrumental in identifying guanosine analogues and functional equivalents. The second patent similarly outlines the use of GPCR22-transformed cell lines and methods for identifying binding compounds, emphasizing the potential applications in drug discovery.
Career Highlights
Giuliani is currently associated with Libramen Naturals Inc., where she continues her research and development efforts. Her innovative work has garnered attention in the scientific community, contributing to the understanding of G-protein coupled receptors and their applications in medicine.
Collaborations
Some of her notable coworkers include Michel P Rathbone and Shucui Jiang, who have collaborated with her on various research projects. Their combined expertise enhances the potential impact of their work in the field.
Conclusion
Patricia Giuliani's contributions to the field of G-protein coupled receptors are noteworthy. Her patents and ongoing research at Libramen Naturals Inc. highlight her role as a leading inventor in biochemistry. Her work is expected to have lasting implications in the identification of new therapeutic compounds.